The one thing that actually separates good programs from bad ones in this category: what happens after you sign up. Anybody can collect a credit card. The programs below earn their spots by being specific about what they compound, what they test, and what you pay.
These are ranked. Criteria: clinical oversight quality, pricing transparency, catalog depth, and how honest each program is about what it does and does not do.
1. FormBlends
Tirzepatide starts at $349 per vial, posted publicly before you fill out a single intake form. No membership layered on top. No phone call required to find the price. That alone puts it in a different category than most of what you’ll read below.
The pharmacy filling these orders is an FDA-registered 503A facility. Three separate tests hit every batch: HPLC for purity, mass spectrometry to confirm molecular identity, and an endotoxin screen for sterility. The published purity figure for tirzepatide sits at 99.3%. Semaglutide runs 99.1%. Those are product-level numbers, not a single blanket certificate of analysis for everything on the shelf. The difference matters.
What makes FormBlends genuinely unusual is the catalog. Most programs sell one or two GLP-1s and nothing else. FormBlends runs the full range, including retatrutide at $389 and cagrilintide at $279, alongside growth hormone peptides, nootropics, and recovery compounds, all dispensed through the same prescriber-supervised model. Ships to 47 states. A licensed physician reviews every order.
Compounded medications are not FDA-approved. That caveat applies across this entire list.
Pro: Per-product purity data and a dual-agonist catalog few programs match.
Con: Not for anyone who wants insurance billing or an integrated coaching program.
2. Mochi Health
Compounded tirzepatide at roughly $199 per month is the headline, but the real story is who writes the prescription. Mochi staffs board-certified obesity-medicine physicians rather than general-practice telehealth clinicians. That distinction shows up in how medications are adjusted, not just initiated. Accepts insurance for branded options like Zepbound. Three- and 12-month commitments bring the price down further.
Pro: Specialist-level clinical oversight at a competitive cash price.
Con: Lighter catalog, focused almost entirely on GLP-1s.
3. Hims & Hers
After March 2026, compounded semaglutide is off the table here. The program now leans on branded Wegovy (around $299/month cash), oral Wegovy (around $249/month), and Zepbound (around $399/month). With commercial insurance and the manufacturer savings card, out-of-pocket cost can fall to nearly zero. The onboarding is fast and the app is polished.
Pro: Strong pathway to branded meds with real insurance support.
Con: No compounded options remaining, so no dual-agonist tier for cash-pay patients.
4. Ro Body
About $74 per month on an annual plan, with medication priced separately. Ro has a dedicated prior-authorization team, which is underrated. Getting a PA approved for Zepbound or Wegovy can take weeks if you don’t know the process. Having people who do this daily is worth something. The platform covers both compounded and branded depending on timing and state.
Pro: Prior-auth support is a genuine operational advantage for insured patients.
Con: Total cost can be hard to forecast until you know what the medication piece adds up to.
5. Henry Meds
Known mainly for speed. Compounded programs in the $179 to $249 range for the first month, with orders often shipping within 24 to 72 hours. The clinical monitoring is lighter than Mochi or Form Health. Works well for someone who already understands GLP-1 dosing and wants minimal friction.
Pro: Fast turnaround and straightforward cash-pay pricing.
Con: Ongoing clinical oversight is not the program’s strong suit.
6. MEDVi
No contracts. No membership fees. Compounded GLP-1 at roughly $179 for the first month, with physician review and 24/7 support included. Smaller footprint than the major names, but the no-commitment model is genuinely useful for people who want to try before committing to a long program.
Pro: Clean entry point with no ongoing financial strings attached.
Con: Less name recognition means fewer patient reviews to cross-reference.
7. Form Health
Expensive. Around $299 per month for the platform, plus labs, plus medication. What you get for that is a physician and a registered dietitian working together, which is uncommon in this space. Best fit for patients with good insurance coverage or a specific reason to want the dual-provider model.
Pro: Physician-plus-dietitian structure is rare and clinically sound.
Con: Total cost can reach $500-plus per month all-in without solid insurance.
Do your own homework before committing to any of these. The dual agonist GLP-1 space is moving fast, pricing shifts regularly, and what’s available in your state may differ from what’s listed here. Loop in whoever manages your broader health before starting anything, especially if you have cardiovascular or metabolic conditions that need monitoring alongside a new medication.
Sources
- FDA: guidance on 503A compounding pharmacies and GLP-1 enforcement actions
- Examine.com: semaglutide and tirzepatide mechanism and evidence summaries
- Cleveland Clinic: overview of GLP-1 receptor agonists and dual-agonist mechanisms
- Drugs.com: tirzepatide and semaglutide prescribing information
- GoodRx: current branded GLP-1 pricing and insurance coverage data
- Verywell Health: telehealth GLP-1 program comparisons
- Healthline: compounded versus branded GLP-1 explainer
[internal: placement #1 | structure: Short ranked list, pros/cons each]
